Dosage form: tablet
Ingredients: chlorpheniramine maleate 4mg
Labeler: Time Cap Labs Inc
NDC Code: 49483-242
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Active ingredient (in each tablet) Chlorpheniramine maleate 4 mg
Uses: temporarily relieves the following symptoms due to hay fever or other upper respiratory allergies:
runny nose, sneezing, itching of the nose or throat, itch, watery eyes
Ask a doctor before use if you have:
glaucoma; a breathing problem such as emphysema or chronic bronchitis; difficulty urinating due to an enlarged prostate gland
Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers.
When using this product:
excitability may occur, especially in children; drowsiness may occur; avoid alcoholic beverages; alcohol, sedatives and tranquilizers may increase drowsiness; use caution when driving a motor vehicle operating machinery
If pregnant or breast-feeding ask a health professional before use.
Adults and children 12 years and over - 1 tablet every 4 to 6 hours, not to exceed 6 tablets in 24 hours
Children 6 to under 12 years of age - 1/2 tablet (break tablet in half) every 4 to 6 hours, not to exceed 3 whole tablets in 24 hours
Children under 6 years of age - do not use
Keep out of the reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
anhydrous lactose, colloidal silicon dioxide, croscarmellose sodium, D-C yellow #10 aluminum lake, magnesium stearate, microcrystalline cellulose, stearic acid.
chlorpheniramine maleate tablet
|Labeler - Time Cap Labs Inc (037052099)|
|Time Cap Labs Inc||037052099||manufacture|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.